Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ana D. Fernandes"'
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 3, Pp 139-144 (2024)
Objective Feedback from fellows‐in‐training (FITs) is important for faculty development and to enrich clinical teaching. We sought to evaluate the effectiveness of traditional online evaluations and a novel compiled verbal feedback mechanism. Met
Externí odkaz:
https://doaj.org/article/3191f056faf64f3e8013dfd651c6164c
Autor:
Damian R. Plichta, Juhi Somani, Matthieu Pichaud, Zachary S. Wallace, Ana D. Fernandes, Cory A. Perugino, Harri Lähdesmäki, John H. Stone, Hera Vlamakis, Daniel C. Chung, Dinesh Khanna, Shiv Pillai, Ramnik J. Xavier
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-14 (2021)
Abstract Background Immunoglobulin G4-related disease (IgG4-RD) and systemic sclerosis (SSc) are rare autoimmune diseases characterized by the presence of CD4+ cytotoxic T cells in the blood as well as inflammation and fibrosis in various organs, but
Externí odkaz:
https://doaj.org/article/c2afd11a7ff94843af149d0af38d4635
Autor:
Alec R. Andrews, Ana D. Fernandes, Seth E. Brownmiller, Yousif Hanna, Mark C. Fisher, Christene A. Huang
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
Objective: This pilot clinical trial examined the efficacy of blocking extracellular Galectin-3 (Gal-3) with modified citrus pectin (MCP), in patients suffering from knee osteoarthritis (OA). Methods: 50 patients were randomized in a 1:1 ratio to rec
Externí odkaz:
https://doaj.org/article/cf8dc3a1d87c4944804f39068a1e2054
Autor:
Mark A, Matza, Cory A, Perugino, Liam, Harvey, Ana D, Fernandes, Zachary S, Wallace, Hang, Liu, Hugues, Allard-Chamard, Shiv, Pillai, John H, Stone
Publikováno v:
Lancet Rheumatol
BACKGROUND: There is strong rationale for interference with T cell co-stimulation in IgG4-related disease (IgG4-RD), but the literature to evaluate this is limited to a single case report. METHODS: We conducted a ten-subject proof-of-concept trial of
Publikováno v:
Arthritis Care & Research. 73:893-897
Objective To evaluate the efficacy and safety of ustekinumab (UST) in giant cell arteritis (GCA). Methods We conducted a prospective, open-label trial of UST in patients with active new-onset or relapsing GCA. Active disease was defined as the presen
Autor:
Cory A. Perugino, Dinesh Khanna, Juhi Somani, Daniel C. Chung, Ramnik J. Xavier, Damian R. Plichta, Matthieu Pichaud, Shiv Pillai, Hera Vlamakis, Zachary S. Wallace, Ana D. Fernandes, Harri Lähdesmäki, John H. Stone
Publikováno v:
Genome Medicine, Vol 13, Iss 1, Pp 1-14 (2021)
Genome Medicine
Genome Medicine
Background Immunoglobulin G4-related disease (IgG4-RD) and systemic sclerosis (SSc) are rare autoimmune diseases characterized by the presence of CD4+ cytotoxic T cells in the blood as well as inflammation and fibrosis in various organs, but they hav
Autor:
Sebastian Unizony, Zsofia D. Drobni, Cory A. Perugino, Deborah S. Collier, Janeth Yinh, Chana A. Sacks, Brian C. Healy, John H. Stone, Ana D. Fernandes, Michael Dougan, Allison K. Scherer, Kathryn Bowman, Harry M Schrager, Crystal M. North, Michael K. Mansour, Nina Lin, Eric A. Meyerowitz, Sarah Nikiforow, Amna Zafar, Rachel Wallwork, Mark Matza, Yuan Di C. Halvorsen, Jorge Fleisher, Jonathan Dau, Michael D. Pincus, Arthur Y. Kim, Matthew J. Frigault, Brittany Weber, David S. Huckins, Ana Maria Bensaci, Liam Harvey, Ruta Shah, Megan Lockwood, Tara K. Thurber, Pritha Sen, Manish Sagar, Andrea S. Foulkes, Tomas G. Neilan, Zeina Dagher, Nora Horick, Ann E. Woolley, Minna J. Kohler, Naomi Serling-Boyd, Sara R. Schoenfeld, Matthew Axelrod, Caroline Cubbison, Marcy B. Bolster, Kristin M. D’Silva
Publikováno v:
New England Journal of Medicine
BACKGROUND: The efficacy of interleukin-6 receptor blockade in hospitalized patients with coronavirus disease 2019 (Covid-19) who are not receiving mechanical ventilation is unclear. METHODS: We performed a randomized, double-blind, placebo-controlle
Publikováno v:
Arthritis careresearchReferences. 73(7)
Autor:
Seth E. Brownmiller, Ana D. Fernandes, Christene A. Huang, Mark Fisher, Yousif Hanna, Alec R. Andrews
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Objective: This pilot clinical trial examined the efficacy of blocking extracellular Galectin-3 (Gal-3) with modified citrus pectin (MCP), in patients suffering from knee osteoarthritis (OA). Methods: 50 patients were randomized in a 1:1 ratio to rec